CD44 and thyroid gland carcinoma: Expression levels of ALDH1A1, CD44, OCT3/4, and ABCG2 gene were 9.78, 7.02, 9.75, and 7.96 times more in stage III thyroid carcinoma than that in benign thyroid mass, respectively (Table 2).